论文部分内容阅读
目的:观察参麦注射液联合常规西药治疗急性心肌梗死合并心源性休克的临床疗效。方法:将80例急性心肌梗死合并心源性休克的患者随机分为2组,各40例。对照组给予常规西药治疗,观察组在对照组治疗基础上加用参麦注射液治疗,2组均连续治疗5天。观察比较2组治疗前后24h尿量、平均动脉压(MAP)、心率及总有效率。结果:治疗后,2组24h尿量、MAP、心率均较前明显改善,与本组治疗前比较,差异有统计学意义(P<0.05);观察组各项指标明显优于对照组,与对照组比较,差异有统计学意义(P<0.05)。结论:参麦注射液联合常规西药治疗急性心肌梗死合并心源性休克,可显著缓解患者临床症状及体征,改善患者24h尿量、MAP及心率,提高临床有效率。
Objective: To observe the clinical efficacy of Shenmai injection combined with conventional western medicine in the treatment of acute myocardial infarction complicated with cardiogenic shock. Methods: Eighty patients with acute myocardial infarction complicated with cardiogenic shock were randomly divided into two groups (n = 40). The control group was given conventional western medicine. The observation group was treated with Shenmai injection on the basis of the control group, and the two groups were treated continuously for 5 days. Observed and compared 24 hours before and after treatment, urine output, mean arterial pressure (MAP), heart rate and total effective rate. Results: After treatment, 24h urine output, MAP and heart rate were significantly improved compared with those before treatment, the difference was statistically significant (P <0.05); the indexes in the observation group were significantly better than those in the control group The difference between the control group, the difference was statistically significant (P <0.05). Conclusion: Shenmai injection combined with conventional western medicine in the treatment of acute myocardial infarction combined with cardiogenic shock can significantly alleviate the clinical symptoms and signs of patients, improve 24h urine output, MAP and heart rate and improve clinical efficiency.